Telomir Pharmaceuticals, Inc.·5

Feb 4, 4:05 PM ET

Aminov Erez 5

5 · Telomir Pharmaceuticals, Inc. · Filed Feb 4, 2025

Insider Transaction Report

Form 5
Period: 2024-12-31
Aminov Erez
DirectorCEO and Chairman
Transactions
  • Sale

    Common Stock

    2024-08-19$6.01/sh200$1,20229,600 total
  • Sale

    Common Stock

    2024-08-19$6.20/sh200$1,24029,600 total
Footnotes (1)
  • [F1]Represents the sale of common stock that should have been reported on Form 4.

Documents

1 file
  • 5
    ownership.xmlPrimary